Hyperbaric Chamber Pressure Differential Disruption of Pathogen Membranes
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for treating viral infections, such as COVID-19, and disinfecting medical equipment are inadequate for rapid and large-scale deployment, especially during pandemics, and do not effectively address post-infection complications or the need for reusable medical masks without significant loss of functionality.
Innovation Solution
A treatment regimen using pressure differentials, ultrasonic cavitation, and magnetic fluctuations within a hyperbaric chamber or pressurized airplane cabin to disrupt the outer membrane of pathogens, combined with hyperbaric oxygen therapy, to weaken or disable viruses like COVID-19, and a method for disinfecting medical equipment by creating pressure differentials within a hyperbaric chamber.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional antiviral drug treatment regimens are used, then patients can be treated for viral infections, but the treatment is not effective for rapid large-scale deployment during pandemics and does not address post-infection complications
Solution Approach 1:
The patent replaces chemical antiviral drug treatment with a physical treatment system using pressure differentials, ultrasonic cavitation, and magnetic fluctuations. This mechanical/physical approach enables rapid large-scale treatment deployment while maintaining effectiveness against viral infections and post-infection complications
Solution Approach 2:
The patent employs dynamic changes in pressure parameters (hyperbaric to hypobaric cycles), ultrasonic frequency parameters, and magnetic field parameters to create a multi-parameter treatment regimen that addresses both active viral infection and post-infection complications, improving treatment effectiveness across different disease stages
2Reliability
If medical equipment is disinfected using conventional methods, then pathogens can be eliminated, but surgical masks and other equipment lose functionality and cannot be reused
Solution Approach 1:
The patent uses ultrasonic vibration and cavitation to disinfect medical equipment including surgical masks. The ultrasonic energy disrupts viral membranes and pathogens without generating enough thermal or mechanical stress to damage the mask materials, enabling effective disinfection while preserving equipment functionality for reuse
Solution Approach 2:
The patent replaces conventional thermal sterilization and chemical disinfection methods with a cold physical disinfection system using pressure differentials and ultrasonic cavitation. This substitution eliminates the need to discard masks and other heat-sensitive equipment after single use, as the disinfection process does not compromise material integrity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach effectively treats viral infections, including post-COVID-19 syndrome, and disinfects medical equipment by disrupting viral membranes, allowing for rapid and large-scale treatment and reuse of masks without compromising their functionality.
Implementation Method 1
A treatment regimen using pressure differentials, ultrasonic cavitation, and magnetic fluctuations within a hyperbaric chamber or pressurized airplane cabin to disrupt the outer membrane of pathogens
Implementation Method 2
A treatment regimen using pressure differentials, ultrasonic cavitation, and magnetic fluctuations within a hyperbaric chamber or pressurized airplane cabin to disrupt the outer membrane of pathogens
Implementation Method 3
A treatment regimen using pressure differentials, ultrasonic cavitation, and magnetic fluctuations within a hyperbaric chamber or pressurized airplane cabin to disrupt the outer membrane of pathogens
Implementation Method 4
administering oxygen in the chamber to a desired level to enhance oxygenation levels in the human being's body
Data Source
AI summary
The present disclosure is directed to methods of treating subject patients (such as humans, animals, plants) suffering from a pathogenic disease such as COVID-19 in humans, via the administration of pressure changes in the patient sufficient to cause a pressure differential to be created between the inside and outside of the outer membrane or envelope of the pathogen thereby destroying or disabling the pathogen. In one embodiment, a hyperbaric chamber is used to administer pressure increases and/or pressure decreases to create such pressure differential. The hyperbaric chamber could comprise a single user or multi-user unit, a pressurized body suit, or the pressurizable fuselage of an aircraft. In another embodiment, patients are placed in an aircraft, and the cabin pressure, while on the ground, or in flight, is adjusted upwardly or downwardly to create such pressure differential. The pressure differential methods can also include the use of external gases to enter the patient's body and/or lungs to facilitate disruption of the pathogen outer membrane as well as application of variations in temperature and/or humidity. A mobile treatment unit is also disclosed. Also disclosed are methods of using ultrasonic cavitation or MRI (or other sonic or magnetic field forces sufficient to disrupt the functionality of the pathogen), or a combination of ultrasound and MRI on the exterior of a patient in a desired anatomical region of the patient to assist with the destruction or disabling of a pathogen infecting that anatomical region of the patient, e.g., the patient's lungs, said method being employed at ambient pressures or in an increased or decreased pressure environment created within a hyperbaric chamber. The ultrasound and/or MRI methodologies could also be used to treat other pathogenically afflicted areas of the patient's body. Additionally, a pressure-differential method of sterilization of medical equipment is disclosed employing a hyperbaric or other pressure or vacuum chamber. Also disclosed is an enhanced method of nonsurgical fat reduction in humans by employing ultrasonic cavitation within a hyperbaric chamber, including the use of HBOT therapies. Furthermore, the use of these methodologies and systems have application in treatment of patients post-infection and in other areas of medicine and health, such as for example, treating wounds, the effects of aging, inflammation, and the effects of other maladies.